Clinical Trial

Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus

Name: Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus — clinical trial record (NCT06852573)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated February 28, 2025 (before its estimated February 20, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is an open, single-arm, phase I clinical study of ZM001 in patients with refractory systemic lupus erythematosus

Trial Details

NCT Number	NCT06852573
Lead Sponsor	Beijing Immunochina Medical Science & Technology Co., Ltd. Collaborators: Peking Union Medical College Hospital
Conditions	Systemic Lupus Erythematosus
Enrollment	18 participants
Start Date	2025-02-20
Primary Completion	2026-02-20 (estimated)
Study Completion	2027-08-20 (estimated)
Updated on ClinicalTrials.gov	2025-02-28